Parkside Financial Bank & Trust’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.64M Buy
27,005
+255
+1% +$14.9K 0.13% 114
2025
Q4
$1.44M Sell
26,750
-81
-0.3% -$3.9K 0.11% 121
2025
Q3
$1.21M Buy
26,831
+898
+3% +$41.9K 0.09% 129
2025
Q2
$1.2M Buy
25,933
+7,803
+43% +$383K 0.13% 120
2025
Q1
$1.11M Buy
18,130
+624
+4% +$36.4K 0.14% 120
2024
Q4
$990K Buy
17,506
+2,030
+13% +$113K 0.13% 124
2024
Q3
$801K Sell
15,476
-180
-1% -$8.44K 0.11% 140
2024
Q2
$650K Sell
15,656
-181
-1% -$8.1K 0.1% 150
2024
Q1
$859K Sell
15,837
-1,180
-7% -$60.1K 0.14% 125
2023
Q4
$873K Sell
17,017
-1,476
-8% -$77.5K 0.16% 111
2023
Q3
$1.07M Buy
18,493
+3,873
+26% +$237K 0.25% 75
2023
Q2
$935K Buy
14,620
+2,548
+21% +$171K 0.22% 79
2023
Q1
$837K Buy
12,072
+572
+5% +$40.3K 0.23% 76
2022
Q4
$827K Buy
11,500
+1,451
+14% +$109K 0.24% 72
2022
Q3
$714K Buy
10,049
+216
+2% +$15.7K 0.23% 71
2022
Q2
$757K Buy
9,833
+1,102
+13% +$83.9K 0.23% 77
2022
Q1
$638K Sell
8,731
-1,458
-14% -$97.9K 0.17% 98
2021
Q4
$636K Buy
10,189
+1,121
+12% +$65.8K 0.16% 105
2021
Q3
$537K Sell
9,068
-4,899
-35% -$323K 0.16% 97
2021
Q2
$933K Sell
13,967
-7,316
-34% -$477K 0.27% 55
2021
Q1
$1.34M Sell
21,283
-3,825
-15% -$238K 0.41% 39
2020
Q4
$1.56M Buy
25,108
+119
+0.5% +$7.32K 0.49% 33
2020
Q3
$1.51M Sell
24,989
-517
-2% -$31.1K 0.53% 32
2020
Q2
$1.5M Sell
25,506
-1,762
-6% -$105K 0.49% 34
2020
Q1
$1.52M Sell
27,268
-161
-0.6% -$9.84K 0.58% 27
2019
Q4
$1.76M Buy
27,429
+9,902
+56% +$567K 0.51% 32
2019
Q3
$889K Buy
17,527
+1,495
+9% +$70.3K 0.29% 55
2019
Q2
$727K Sell
16,032
-434
-3% -$20.2K 0.24% 64
2019
Q1
$786K Sell
16,466
-512
-3% -$25.5K 0.27% 58
2018
Q4
$882K Buy
16,978
+946
+6% +$50.8K 0.32% 47
2018
Q3
$995K Sell
16,032
-4
-0% -$237 0.34% 44
2018
Q2
$887K Buy
16,036
+173
+1% +$9.34K 0.33% 51
2018
Q1
$1M Sell
15,863
-3,927
-20% -$253K 0.38% 44
2017
Q4
$1.21M Buy
19,790
+879
+5% +$55K 0.44% 39
2017
Q3
$1.21M Buy
18,911
+24
+0.1% +$1.4K 0.47% 33
2017
Q2
$1.05M Sell
18,887
-1,719
-8% -$93.5K 0.43% 45
2017
Q1
$1.12M Buy
20,606
+532
+3% +$29.2K 0.48% 42
2016
Q4
$1.17M Buy
20,074
+9,813
+96% +$536K 0.51% 38
2016
Q3
$553K Buy
10,261
+439
+4% +$28.2K 0.25% 75
2016
Q2
$722K Buy
9,822
+347
+4% +$24.5K 0.35% 59
2016
Q1
$606K Sell
9,475
-3,982
-30% -$251K 0.31% 66
2015
Q4
$925K Sell
13,457
-146
-1% -$9.65K 0.46% 40
2015
Q3
$805K Sell
13,603
-11,461
-46% -$727K 0.46% 41
2015
Q2
$1.67M Buy
25,064
+209
+0.8% +$13.8K 0.89% 25
2015
Q1
$1.6M Sell
24,855
-310
-1% -$19.4K 0.86% 28
2014
Q4
$1.49M Sell
25,165
-719
-3% -$40.5K 0.83% 31
2014
Q3
$1.32M Buy
25,884
+116
+0.5% +$5.79K 0.8% 33
2014
Q2
$1.25M Sell
25,768
-1,773
-6% -$87.4K 0.74% 37
2014
Q1
$1.43M Sell
27,541
-122
-0.4% -$6.49K 0.9% 30
2013
Q4
$1.47M Buy
27,663
+16
+0.1% +$815 1% 24
2013
Q3
$1.28M Sell
27,647
-456
-2% -$20K 1% 28
2013
Q2
$1.26M Buy
+28,103
New +$1.22M 0.99% 29

Other funds holding BMY

Parkside Financial Bank & Trust's BMY Position: Q1 2026 in Review

Parkside Financial Bank & Trust increased its Bristol-Myers Squibb (BMY) stake by 0.95% in Q1 2026, buying an estimated $14.9K and bringing the position to 27,005 shares worth $1.64M. The position accounts for 0.13% of the portfolio, ranked #114.

Parkside Financial Bank & Trust first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.76M in Q4 2019. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Parkside Financial Bank & Trust held 27,005 shares of Bristol-Myers Squibb worth $1.64M as of Q1 2026.
  • Parkside Financial Bank & Trust bought 255 Bristol-Myers Squibb shares in Q1 2026, an estimated $14.9K.
  • Bristol-Myers Squibb made up 0.13% of Parkside Financial Bank & Trust's portfolio in Q1 2026, its #114 holding.
  • Parkside Financial Bank & Trust first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
  • Parkside Financial Bank & Trust's Bristol-Myers Squibb position peaked at $1.76M in Q4 2019.
  • 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.